• 16TH FEBRUARY 2023

    February 2023 Price Concessions 1st Update

    The Department of Health and Social Care (DHSC) has today (16/02/2023) granted the following initial list of price concessions for February 2023. Drug Pack Size Price concession Amisulpride 100mg tablets 60 £20.29 Amisulpride 200mg tablets 60 £33.92 Amisulpride 50mg tablets 60 £13.09 Amoxicillin 250mg/5ml oral suspension 100 £4.34 Atenolol 25mg tablets 28 £1.44 Baclofen 5mg/5ml

    Read more
    • 15TH FEBRUARY 2023

    Medicine Supply Notification: Meptazinol (Meptid® ) 200mg film-coated tablets

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Meptazinol (Meptid®) 200mg film-coated tablets. MSN/2023/016 Tier 2 – medium impact Date of issue 15th February 2023 Meptazinol (Meptid®) 200mg film-coated tablets are out of stock until late June 2023. Alternative analgesic products including non-opioids remain available. A copy of this

    Read more
    • 15TH FEBRUARY 2023

    Medicine Supply Notification: Medroxyprogesterone (Provera® ) 2.5mg tablets

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Medroxyprogesterone (Provera®) 2.5mg tablets. MSN/2023/016 Tier 3 – high impact Date of issue 15th February 2023 Medroxyprogesterone (Provera®) 2.5mg tablets are out of stock until mid-March 2023. Medroxyprogesterone (Provera®) 5mg and 10mg tablets remain available but cannot support an uplift in

    Read more
    • 15TH FEBRUARY 2023

    Medicine Supply Notification: Lamotrigine 5mg dispersible tablets

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Lamotrigine 5mg dispersible tablets. MSN/2023/017 Tier 2 – medium impact Date of issue 15th February 2023 Lamotrigine 5mg dispersible tablets are out of stock until late March 2023 Branded lamotrigine (Lamictal®) 2mg and 5mg dispersible remain available but are unable to

    Read more
    • 15TH FEBRUARY 2023

    Medicine Supply Notification: Promethazine hydrochloride (Phenergan® elixir) 5mg/5ml oral solution sugar free

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Promethazine hydrochloride (Phenergan® elixir) 5mg/5ml oral solution sugar free. MSN/2023/015 Tier 2 – medium impact Date of issue 15th February 2023 Promethazine hydrochloride (Phenergan® elixir) 5mg/5ml oral solution sugar free is out of stock until mid-April 2023. Promethazine hydrochloride 10mg and

    Read more
    • 15TH FEBRUARY 2023

    Reminder: Have you made your PQS declaration yet?

    Community pharmacy contractors have until 11.59pm on Friday 3rd March 2023 to make their Pharmacy Quality Scheme (PQS) 2022/23 declaration through the MYS portal, as the window for claiming this payment will then close.  Contractors must have evidence to demonstrate meeting the gateway criteria and the domains that they have claimed for by the end of 31st March 2023.

    Read more
    • 10TH FEBRUARY 2023

    Further extension to SSP005 for Fluoxetine 10mg tablets

    Update 10/02/2023 – The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for Fluoxetine 10mg tablets (SSP005). SSP005 for Fluoxetine 10mg tablets was previously expected to expire on 7 December 2022 but the end date has been further extended to Friday 31 March 2023. This will

    Read more
    • 9TH FEBRUARY 2023

    Dexcom One Transmitter to be added to March 2023 Drug Tariff

    Following representations from PSNC and Dexcom International Ltd, the Department of Health of Social Care (DHSC) has confirmed that the Dexcom One Transmitter will be added to Part IXA of the March 2023 Drug Tariff. Previously, patients were advised to obtain the free-of-charge Dexcom One transmitters directly from the pharmacies, without a prescription, as the original Drug Tariff application

    Read more
    • 9TH FEBRUARY 2023

    NMS: Voluntary quarterly data returns

    NHS England is asking community pharmacy contractors to voluntarily submit New Medicine Service (NMS) quarterly summary data to the NHS Business Services Authority (NHSBSA) for Quarter 3 (Q3) 2022/23. The mandatory requirement to submit this data has been suspended since 2020, due to the COVID-19 pandemic. NHS England want to re-start collection of the quarterly

    Read more
    • 8TH FEBRUARY 2023

    Reminder: National audit 2022/23 – valproate

    By 31st March 2023, all community pharmacy contractors must have completed the 2022/23 national clinical audit on valproate, over a six-week consecutive period.  The audit aims to reduce the potential harm caused by taking valproate during pregnancy. For contractors who have not yet commenced the audit, the last day on which you can start the

    Read more